Mechanism-based model for tumor drug resistance

Area of Science:

• * Mathematical oncology
• * Cancer cell biology
• * Drug resistance mechanisms

Background:

• * Tumor resistance to cytotoxic agents is a major challenge in cancer therapy.
• * Mathematical models can elucidate resistance mechanisms and guide treatment strategies.
• * Pyrimidine synthesis is crucial for cancer cell proliferation.

Purpose of the Study:

• * To develop a mathematical model for tumor growth kinetics based on normally distributed cell growth rates.
• * To investigate tumor cell resistance to the pyrimidine antimetabolite N-phosphonacetyl-L-aspartate (PALA).
• * To analyze the role of pyrimidine synthesis and salvage metabolism in acquired drug resistance.

Main Methods:

• * Development of a rate-normal model for tumor growth kinetics.
• * Use of an ovarian carcinoma cell line (2008) and PALA-resistant variants.
• * Analysis of growth curves using probit plots and dose-response data.
• * Correlation of resistance shifts with uridine transport rates.

Main Results:

• * The model accurately describes growth curves and predicts resistance development in PALA-treated cells.
• * Resistant variants showed a parallel rightward shift in probit plots, confirming model predictions.
• * A strong correlation (r=0.99) between dose-response shifts and uridine transport suggests salvage metabolism's role in PALA resistance.
• * The model detected synergy between dipyridamole and PALA.

Conclusions:

• * The rate-normal model provides a framework for understanding tumor cell resistance to PALA.
• * Salvage metabolism is a key factor in acquired resistance to pyrimidine antimetabolites.
• * The model has broad applicability for studying other resistance mechanisms, including gene amplification.